维普中文期刊产品整合服务
54篇 您的检索式:作者名="Buffoli"
    题名 作者 年代 出处 被引量
1Non-variceal upper gastrointestinal bleeding: Rescue treatment with a modified cyanoacrylate显示文摘AIM To evaluate the safety and efficacy of a modified cyanoacrylate [N-butyl-2-cyanoacrylate associated with methacryloxysulfolane(NBCA + MS)] to treat nonvariceal upper gastrointestinal bleeding(NV-UGIB).METHODS In our retrospective study we took into account 579 out of 1177 patients receiving endoscopic treatment for NV-UGIB admitted to our institution from 2008 to 2015; the remaining 598 patients were treated with other treatments. Initial hemostasis was not achieved in 45 of 579 patients; early rebleeding occurred in 12 of 579 patients. Thirty-three patients were treated with modified cyanoacrylate: 27 patients had duodenal, gastric or anastomotic ulcers, 3 had post-mucosectomy bleeding, 2 had Dieulafoy's lesions, and 1 had duodenal diverticular bleeding.RESULTS Of the 45 patients treated endoscopically without initialhemostasis or with early rebleeding, 33(76.7%) were treated with modified cyanoacrylate glue, 16(37.2%) underwent surgery, and 3(7.0%) were treated with selective transarterial embolization. The mean age of patients treated with NBCA + MS(23 males and 10 females) was 74.5 years. Modified cyanoacrylate was used in 24 patients during the first endoscopy and in 9 patients experiencing rebleeding. Overall, hemostasis was achieved in 26 of 33 patients(78.8%): 19 out of 24(79.2%) during the first endoscopy and in 7 out of 9(77.8%) among early rebleeders. Two patients(22.2%) not responding to cyanoacrylate treatment were treated with surgery or transarterial embolization. One patient had early rebleeding after treatment with cyanoacrylate. No late rebleeding during the follow-up or complications related to the glue injection were recorded.CONCLUSION Modified cyanoacrylate solved definitively NV-UGIB after failure of conventional treatment. Some reported life-threatening adverse events with other formulations, advise to use it as last option.Roberto Grassia Pietro Capone Elena Iiritano Katerina Vjero Fabrizio Cereatti Mario Martinotti Gabriele Rozzi Federico Buffoli 2016World Journal of Gastroenterology2016,22,48:8
2Neuroendocrine carcinomas arising in ulcerative colitis:Coincidences or possible correlations?显示文摘Patients with in· ammatory bowel disease (IBD) are at increased risk of colorectal malignancies. Adenocarcinoma is the commonest type of colorectal neoplasm associated with ulcerative colitis (UC) and Crohn's disease, but other types of epithelial and non-epithelial tumors have also been described in inflamed bowel. With regards to non-epithelial malignancies, lymphomas and sarcomas represent the largest group of tumors reported in association with IBD, especially in immunosuppressed patients. Carcinoids and in particular neuroendocrine neoplasms other than carcinoids (NENs) are rare tumors and are infrequently described in the setting of IBD. Thus, this association requires further investigation. We report two cases of neoplasms arising in mild left-sided UC with immuno-histochemical staining for neuroendocrine markers: a large cell and a small cell neuroendocrine carcinoma of the rectum. The two patients were different in age (35 years vs 77 years) and disease duration (11 years vs 27 years), and both had never received immuno-suppressant drugs. Although the patients underwent regular endoscopic and histological follow-up, the two neoplasms were locally advanced at diagnosis. One of the two patients developed multiple liver metastases and died 15 mo after diagnosis. These findings confirm the aggressiveness and the poor prognosis of NENs compared to colorectal adenocarcinoma. While carcinoids seem to be coincidentally associated with IBD, NENs may also arise in this setting. In fact, long-stand-ing in· ammation could be directly responsible for thedevelopment of pancellular dysplasia involving epithelial, goblet, Paneth and neuroendocrine cells. It has yet to be established which IBD patients have a higher risk of developing NENs.Roberto Grassia Paolo Bodini Paolo Dizioli Teresa Staiano Elena Iiritano Guglielmo Bianchi Federico Buffoli 2009World Journal of Gastroenterology2009,15,33:4
3Endoscopic “retroperitoneal fatpexy” of a large ERCP-related jejunal perforation by using a new over–the-scope clip device in Billroth II anatomy (with video)显示文摘Federico Buffoli Roberto Grassia Elena Iiritano Guglielmo Bianchi Paolo Dizioli Teresa Staiano 2012Gastrointestinal Endoscopy2012,,5:2
4Change in renal heme oxygenase expression in cyclosporine A-induced injury显示文摘Rezzani R Rodella L Buffoli B 2005J Histochem Cytochem2005,53,1:1
5The no-flow during percutaneous coronary intervention after primary angioplasty: incidence, predictive factors, and long-term outcome 显示文摘Romano M Buffoli F Tomasl L 2008J CardiovaseMed2008,9,:1
6The no-reflow phenomenon in acute myocardial infarction after primary angioplasty:incidence,predictive factors,and long-term outcomes显示文摘Romano M Buffoli F Tomasi L 0,,:1
7No reflow in patients undergoing primary angioplasty for acute myocardial infarction at high risk: incidence and predictive factors显示文摘Romano M Buffoli F Lettieri C 2005Minerva Cardioangiol2005,53,:1
8Endothelium and its alterations in cardiovascular diseases:life style intervention显示文摘Favero G Paganelli C Buffoli B 2014Biomed Res Int2014,2014,80:1
9No reflow in patients undergoing primary angioplasty for acute myocardial infarction at high risk: incidence and preictive factors 显示文摘Romano M Buffoli F Lettieri C 2005Minnerva Cardioangiol2005,53,1:1
10The no-reflow phenomenon in acute myocardial infarction after primary angioplasty : incidence, predictive factors, and long-term outcomes显示文摘ROMANO M BUFFOLI F TOMASIL 2008J Cardiovase Med2008,9,1:1
11Cyelosporine A induces vascular fibrosis and heat shock protein expression in rat显示文摘Rezzani R Rodella L Buffoli B 2005Int Immunopharmacol2005,5,1:1
12The no-reflow phenomenon in acute myocardial infarction after primary angioplasty:incidence,predictive factors,and long-term outcomes显示文摘Romano M Buffoli F Tonmasi L 2008Cardiovascular Med2008,9,1:1
13The no-reflow phenomenon in acute myocardial infarction after primary angioplasty; incidence, predictive factors, and long-term outcomes显示文摘Romano M Buffoli F Tomasi L 2008J Cardiovasc Med2008,9,1:1
14Provinol preventsCsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression显示文摘Buffoli B Pechanova O Kojsova S 2005J Histochem Cytochem2005,53,12:1
15Preinvasive colorectal lesion transcriptomes correlate with endoscopic morphology (polypoid vs. nonpolypoid)显示文摘Elisa Cattaneo Endre Laczko Federico Buffoli Fausto Zorzi Maria Antonia Bianco Mirco Menigatti Zdena Bartosova Ritva Haider Birgit Helmchen Jacob Sabates‐Bellver Amit Tiwari Josef Jiricny Giancarlo Marra 2011EMBO Mol Med2011,,6:1
16The no-reflow phenomenon in acute myocardial infarction after primary angioplasty:incidence,predictive factors,and long- term outcomes显示文摘Romano M Buffoli F Tomasi L 0,,:1
17No reflow in patients undergoing primary angioplasty for acute myocardial infarction at high risk: incidence and predictive factors 显示文摘Romano M Buffoli F Lettieri C 2005Minerva Cardioangiol2005,53,1:1
18The no-reflow phe-nomenon in acute myocardial infarction after primary angio-plasty :incidence, predictive factors, and long-term out-comes 显示文摘Romano M Buffoli F Tomasi L 2008J Cardiovasc Med ( Hagerstown)2008,9,1:1
19The no-reflow phenomenon in acutemyocardial infarction after primary angioplasty:incidence,predictive factors,and long-term outcomes显示文摘Romano M Buffoli F Tomasi L 0,,:1
20The no-reflow phe- nomenon in acute myocardial infarction after primary angio- plasty : incidence, predictive factors, and long-term out- comes显示文摘Romano M Buffoli F Tomasi L 2008J Cardiovasc ned2008,9,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费